SCHEMBL18706235

SCHEMBL18706235

COC(=O)c1cc(Br)cc(N=CN(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 2/20 0.47
▸ KDM4E B2RXH2 4/20 0.39
▸ POLB P06746 2/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ CA1 P00915 3/20 0.39
▸ CA2 P00918 3/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA7 P43166 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ CA14 Q9ULX7 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ XDH P47989 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18706232 1.00 NOTUM (0.47) NOTUMKDM4EPOLBALDH1A1CA1
SCHEMBL28133308 0.76 CA1 (0.58) KDM4EALDH1A1CA1CA2CA12
SCHEMBL28133309 0.76 CA1 (0.58) KDM4EALDH1A1CA1CA2CA12
SCHEMBL184614 0.75 NOTUM (0.67) NOTUMKDM4EPOLBALDH1A1CA1
Methyl 3,5-Dibromobenzoate SCHEMBL2408987 0.75 NOTUM (0.67) NOTUMKDM4EPOLBALDH1A1CA1
SCHEMBL17825624 0.73 KMT2A (0.50) KDM4EPOLBALDH1A1CA1CA2
SCHEMBL17825623 0.73 KMT2A (0.50) KDM4EPOLBALDH1A1CA1CA2
SCHEMBL23899105 0.71 ALDH1A1 (0.37) KDM4EALDH1A1TSHRHTTLMNA
SCHEMBL16396395 0.71 NOTUM (0.54) NOTUMKDM4EPOLBALDH1A1CA1
SCHEMBL13053809 0.71 KDM4E (0.49) KDM4EPOLBALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3359537-B1 TRIAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2020-03-25 — — EP disclosed
US-10273217-B2 Triazole derivatives HOFFMANN-LA ROCHE INC. (US) 2019-04-30 — — US disclosed
US-20180237401-A1 TRIAZOLE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2018-08-23 — — US disclosed
WO-2017060202-A1 TRIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2017-04-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180237401-A1 TRIAZOLE DERIVATIVES MC2R, MC3R, OXTR NOTUM 4195/4885KDM4E 2864/4885POLB 2378/4885
US-10273217-B2 Triazole derivatives MC2R, MC3R, OXTR NOTUM 4195/4885KDM4E 2864/4885POLB 2378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback